Vinpocetine is the forthcoming adjuvant agent in the management of COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Future Science OA"
DOI: 10.2144/fsoa-2021-0099
Abstract: Vinpocetine (VPN) is an alkaloid derivative of vincamine inhibits phosphodiesterase type 1 that increase cyclic guanosine monophosphate and cyclic adenosine monophosphate. VPN have anti-inflammatory and antioxidant effects with suppression release of pro-inflammatory cytokines. Moreover, VPN… read more here.
Keywords: agent management; forthcoming adjuvant; vinpocetine; covid ... See more keywords